The Macedonian unit of the Croatian company has secured regulatory clearance for six molecules for cardiovascular, gastroenterological and neurological treatments based on which it will market 11 products on the local market, the company said in a statement.
PharmaS has so far registered 24 molecules in Croatia, 19 in Serbia, 14 in Bosnia and five in Kosovo.
The Popovaca-based company (www.pharmas.hr) was founded in 2008 by Croatian businessman Luka Rajic.